Vial Announces the Addition of Dr. Christopher Sweeney of SAiGENCI and the University of Adelaide to their Oncology CRO Scientific Advisory Board

SAN FRANCISCO, Dec. 19, 2022 /PRNewswire/ -- Vial, a global tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Christopher Sweeney, MBBS, to Vial's scientific advisory board (SAB). Dr. Sweeney will work closely with the company's...

Click to view original post